[采用ABVD和BACOP方案治疗III期和IV期霍奇金病的结果] - Suppr | 超能文献

[Results of the treatment of Hodgkin's disease stage III and IV using the ABVD and BACOP programs].

作者信息

Leszko B, Słomkowski M, Przybyszewska M, Apel D, Pawelski S

出版信息

Acta Haematol Pol. 1986 Jul-Dec;17(3-4):81-90.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Results of the treatment of Hodgkin's disease stage III and IV using the ABVD and BACOP programs].[采用ABVD和BACOP方案治疗III期和IV期霍奇金病的结果]

Acta Haematol Pol. 1986 Jul-Dec;17(3-4):81-90.

2

MOPP, ABVD, or both to treat Hodgkin's disease.采用MOPP方案、ABVD方案或两者联合治疗霍奇金淋巴瘤。

N Engl J Med. 1993 Apr 8;328(14):1045; author reply 1045-6. doi: 10.1056/NEJM199304083281417.

3

Long-term follow-up of survival in Hodgkin's lymphoma.霍奇金淋巴瘤生存情况的长期随访

N Engl J Med. 2009 Dec 10;361(24):2390-1. doi: 10.1056/NEJMc0906731.

4

Treatment of childhood Hodgkin's disease with chemotherapy alone. Experiences from the Royal Children's Hospital, Melbourne.单纯化疗治疗儿童霍奇金病。墨尔本皇家儿童医院的经验。

Cancer Treat Res. 1989;41:241-6.

5

Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.不同 Hodgkin 病化放疗联合方案的心肺毒性。

Anticancer Res. 2010 Oct;30(10):4381-7.

6

Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.霍奇金病放化疗后不同程度肺毒性患者运动时的心肺反应

Anticancer Res. 2009 Feb;29(2):777-83.

7

[Cardiogenic shock during polychemotherapy in a patient with Hodgkin's disease].[霍奇金病患者多药化疗期间的心源性休克]

Kardiol Pol. 1986;29(8):555-9.

8

Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease.化疗期间低急性血液学毒性预示晚期霍奇金淋巴瘤疾病控制效果降低。

Ann Hematol. 2004 Mar;83(3):176-82. doi: 10.1007/s00277-003-0727-9. Epub 2003 Dec 12.

9

Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.以环磷酰胺、长春新碱、丙卡巴肼、泼尼松、阿霉素、博来霉素和长春花碱组成的联合化疗方案（C-MOPP/ABV）作为晚期霍奇金病患者的一线治疗方案。

Cancer. 2000 May 1;88(9):2142-8.

10

Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.洛莫司汀、依托泊苷、长春地辛和地塞米松（CEVD）用于对环磷酰胺、长春新碱、丙卡巴肼和泼尼松（COPP）以及多柔比星、博来霉素、长春碱和达卡巴嗪（ABVD）耐药的霍奇金淋巴瘤：德国霍奇金研究组的一项多中心试验

Cancer Treat Rep. 1987 Dec;71(12):1203-7.